OM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients With Chronic Rhinosinusitis
Utilizing clinical data from electronic health records related to endoscopic sinus surgeries, Medtronic and OM1 found PROPEL devices result in fewer postoperative care needs in chronic rhinosinusitis patients April 09, 2024 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, the leading AI and insights-driven technology and data company specializing in personalized medicine, evidence generation, and[…]